Summary
In this chapter the historical events of apoptotic research are followed by (a) the relationship of apoptosis to the genetic communication, (b) characterization of apoptosis and necrosis, (c) induction and chemical inducers of apoptosis, (d) apoptotic pathways, (e) antiapoptotic pathways and (f) apoptosis protocols.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adachi, S., Cross, A.R., Babior, B.M. and Gottlieb, R.A. (1997). Bcl-2 and the outer mitochondrial membrane in the inactivation of cytochrome c during Fas-mediated apoptosis. J Biol Chem. 272, 21878–21882.
Adler, V., Fuchs, S.Y., Kim, J., Kraft, A., King, M.P., Pelling, J. and Ronai, Z. (1995). Jun-NH2-terminal kinase activation mediated by UV-induced DNA lesions in melanoma and fibroblast cells. Cell Growth Differ. 6, 1437–1446.
Adler, V., Pincus, M.R., Minamoto, T., Fuchs, S.Y., Bluth, M.J., Brandt-Rauf, P.W., Friedman, F.K., Robinson, R.C., Chen, J.M., Wang, X.W., Harris, C.C. and Ronai, Z. (1997). Conformation-dependent phosphorylation of p53. Proc Natl Acad Sci USA 94, 1686–1691.
Alderson, M.R., Tough, T.W., Davis, S.T., Braddy, S., Falk, B., Schooley, K.A., Goodwin, R.G., Smith, C.A., Ramsdell, F. and Lynch, D.H. (1995). Fas ligandmediates activationinduced cell death in human T lymphocytes. J Exp Med. 181, 71–77.
Almog, N. and Rotter, V. (1998). An insight into the life of p53: a protein coping with many function! Biochim Biophys Acta. 1378, R43–R54.
Alnemri, E.S., Livingston, D.J., Nicholson, D.W. et al. (1996). Human ICE/CED-3 protease nomenclature. Cell. 87, 171.
Amakawa, R., Hakem, A., Kundig, T.M., Matsuyama, T., Simard, J.J., Timms, E., Wakeham, A., Mittruecker, H.W., Griesser, H., Takimoto, H., Schmits, R., Shahinian, A., Ohashi, P., Penninger, J.M. and Mak, T.W. (1996). Impaired negative selection of T cells in Hodgkin’s disease antigen CD30-deficient mice. Cell. 84, 551–562.
Ameisen, J.C. (2002). On the origin, evolution, and nature of programmed cell death: a timeline of four billion years. Cell Death Differ. 9, 367–93.
André, N. (2003). Hippocrates of Cos and apoptosis. Lancet. 361, 1306.
Appella, E. and Anderson, C.W. (2001). Post-translational modifications and activation of p53 by genotoxic stresses. Eur J Biochem. 268, 2764–2772. Review.
Arends, M.J. and Wyllie, A.H., (1991). Apoptosis: mechanisms and roles in pathology. Int Rev Exp Pathol. 52, 223–254.
Asher, G., Lotem, J., Kama, R., Sachs, L. and Shaul, Y. (2002). NQO1 stabilizes p53 through a distinct pathway. Proc Natl Acad Sci USA. 99, 3099–3104.
Ashush, H., Rozenszajn, L.A., Blass, M., Barda-Saad, M., Azimov, D., Radnay, J., Zipori, D. and Rosenschein, U. (2000). Apoptosis induction of human myeloid leukemic cells by ultrasound exposure. Cancer Res. 60, 1014–1020.
Babiss, L.E., Gisberg, H.S., Darnell, J.E. Jr. (1985). Adenovirus E1B proteins are required for accumulation of late viral mRNA and for effects on cellular mRNA translation and transport. Mol Cell Biol. 5, 2552–2558.
Bacher, M., Rausch, U., Goebel, H.W., Polzar, B., Mannherz, H.G. and Aumuller, G. (1993). Stromal and epithelial cells from rat ventral prostate during androgen deprivation and estrogen treatment-regulation of transcription. Exp Clin Endocrinol. 101, 78–86.
Baker, S.J., Fearon, E.R., Nigro, J.M., Hamilton, S.R., Preisinger, A.C., Jessup, J.M., Van Tuinen, P., Ledebetter, D.H., Barker, D.F., Nakamura, Y., White, R. and Vogelstein, B. (1989). Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science. 244, 217–221.
Bálint, È. and Vousden, KH. (2001). Activation and activities of the p53 tumour suppressor protein. Br J Cancer 85, 1813–1823.
Bánfalvi, G., Littlefield, N., Hass, B., Mikhailova, M., Csuka, I., Szepessy, E. and Chou, W.M. (2000). Effect of cadmium on the relationship between replicative and repair DNA synthesis in synchronized cho cells. Eur J Biochem. 267, 6580–6585.
Bánfalvi, G., Klaisz, M., Ujvarosi, K., Trencsenyi, G., Rozsa, D. and Nagy, G. (2007). Gamma irradiation induced apoptotic changes in the chromatin structure of human erythroleukemia K562 cells. Apoptosis. 12, 2271–2283.
Bánfalvi, G., Mikhailova, M., Poirier, L.A. and Chou, M.W. (1997). Multiple subphases of DNA replication in Chinese hamster ovary (CHO-K1) cells. DNA Cell Biol. 16, 1493–1498.
Bao, H., Jacobs-Helber, S.M., Lawson, A.E., Penta, K., Wickrema, A. and Sawyer, S.T. (1999). Protein kinase B (c-Akt), phosphatidylinositol 3-kinase, and STAT5 are activated by erythropoietin (EPO) in HCD57 erythroid cells but are constitutively active in an EPO-independent, apoptosis-resistant subclone (HCD57-SREI cells). Blood. 93, 3757–3773.
Bartek, J. and Lukas, J. (2001). Mammalian G1- and S-phase checkpoints in response to DNA damage. Curr Opin Cell Biol. 13, 738–747.
Bartek, J., Lukas, C. and Lukas, J. (2004). Checking on DNA damage in S phase. Nat Rev Mol Cell Biol. 5, 792–804.
Beere, H.M., Chresta, C.M., ALEJO-Herberg, A., Skladanowski, A., Dive, C., Larsen, A.K. and Hickman, J.A. (1995). Investigation of the mechanism of higher order chromatin fragmentation observed in drug-induced apoptosis. Mol Pharmacol. 47, 986–996.
Bellairs, R. (1961). Cell death in chick embryos as studied by electromicroscopy. J Anat. 95, 54–60.
Berman-Frank, I., Bidle, K.D. and Falkowski, P.G. (2004). The demise of the marine cyanobacteria, Trichodesmium spp., via an autocatalysed cell death pathway. Limnol Oceanogr. 49, 997–1005.
Bernstein, E. and Hake, S.B. (2006). The nucleosome: a little variation goes a long way. Biochem Cell Biol. 84, 505–517.
Bitar, K.N. (2002). HSP27 phosphorylation and interaction with actin-myosin in smooth muscle contraction. Am J Physiol Gastrointest Liver Physiol. 282, G894–903.
Blagosklonny, M.V. (2001). Do VHL and HIF-1 mirror p53 and Mdm-2? Degradation-transactivation loops of oncoproteins and tumour suppressors. Oncogene. 20, 395–398. Review.
Blagosklonny, M.V. (2002). P53: An ubiquitous target of anticancer drugs. Int J Cancer, 98, 161–166.
Boldin, M.P., Goncharov, T.M., Goltsev, Y.V. and Wallach, D. (1996). Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/Apo-1 and TNF receptor induced cell death. Cell. 85, 803–815.
Boldin, M.P., Varfolomeev, E.E., Pancer, Z., Mett, I.L., Camonis, J.H. and Wallach, D. (1995). A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J Biol Chem. 270, 7795–7798.
Bossy-Wetzel, E. and Green, D.R. (1999). Apoptosis: checkpoint at the mitochondrial frontier. Mutation Research/DNA Repair. 434, 243–251.
Bossy-Wetzel, E., Newmeyer, D.D. and Green, D.R. (1998). Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO J. 17, 37–49.
Broker, L.E., Kruyt, F.A., Giaccone, G. (2005). Cell death independent of caspases: a review. Clin Cancer Res. 11, 62–3155.
Brown, D.G., Sun, X.M. and Cohen, G.M. (1993). Dexamethasoneinduced apoptosis involves cleavage of DNA to large fragments prior to internucleosomal fragmentation; J Biol Chem. 268, 3037–3039.
Bruey, J.M., Ducasse, C., Bonniaud, P., Ravagnan, L., Susin, S.A., Diaz-Latoud, C., Gurbuxani, S., Arrigo, A.P., Kroemer, G., Solary, E. and Garrido, C. (2000a). Hsp27 negatively regulates cell death by interacting with cytochrome c. Nat Cell Biol. 2, 645–652.
Bruey, J.M., Paul, C., Fromentin, A., Hilpert, S., Arrigo, A.P., Solary, E. and Garrido, C. (2000b). Differential regulation of HSP27 oligomerization in tumour cells grown in vitro and in vivo. Oncogene. 19, 4855–63.
Bryan, T.M. and Reddel, R.R. (1994). SV40-induced immortalization of human cells. Crit Rev Oncog. 5, 5331–5357.
Bursch, W., Ellinger, A., Gerner, C., Fröhwein, U. and Schulte-Hermann, R. (2000). Programmed cell death (PCD). Apoptosis, autophagic PCD, or others? Ann N Y Acad Sci. 926, 1–12.
Büttner, S., Carmona-Gutierrez, D., Vitale, I., Castedo, M., Ruli, D., Eisenberg, T., Kroemer, G. and Madeo, F. (2007). Depletion of endonuclease G selectively kills polyploid cells. Cell Cycle. 6, 1072–1076.
Caelles, C., Helmberg, A. and Karin, M. (1994). p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature. 370, 220–223.
Cai, J. and Jones, D.P. (1998). Superoxide in apoptosis. Mitochondrial generation triggered by cytochrome c loss. J Biol Chem. 273, 11401–11404.
Casiano, C.A., Ochs, R.L. and Tan, E.M. (1998). Distinct cleavage products of nuclear proteins in apoptosis and necrosis revealed by autoantibody probes. Cell Death Differ. 5, 183–90.
Casiano, C.A. and Tan, E.M. (1996). Antinuclear autoantibodies: probes for defining proteolytic events associated with apoptosis. Mol Biol Rep. 23, 211–216. Review.
Castedo, M., Perfettini, J.-L., Roumier, T., Andreau, K., Medema, R., Kroemer, G. (2004). Cell death by mitotic catastrophe: a molecular definition. Oncogene. 23, 2825–2837.
Certo, M., Del Gaizo Moore, V., Nishino, M., Wei, G., Korsmeyer, S., Armstrong, S.A. and Letai, A. (2006). Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members. Cancer Cell. 9, 351–361.
Chakravarti, D. and Hong, R. (2003). SET-ting the stage for life and death. Cell. 112, 589–591.
Chang, Y.C., Chang, H.W., Liao, C.B., Liu, Y.C. (2002). The role of p53, DNA repair and oxidative stress in UVC induction of PCNA expression. Ann N Y Acad Sci. 973, 384–391.
Charette, S.J. and Landry, J. (2000). The interaction of HSP27 with Daxx identifies a potential regulatory role of HSP27 in Fas-induced apoptosis. Ann N Y Acad Sci. 926, 126–131.
Charette, S.J., Lavoie, J.N., Lambert, H. and Landry, J. (2000). Inhibition of Daxx-mediated apoptosis by heat shock protein 27. Mol Cell Biol. 20, 7602–7612.
Chen, Y.R., Meyer, C.F. and Tan, T.H. (1996). Persistent activation of c-Jun N-terminal kinase 1 (JNK1) in gamma radiation-induced apoptosis. J Biol Chem. 271, 631–634.
Chinnaiyan, A.M., O’rourke, K., Lane, B.R. and Dixit, V.M. (1997). Interaction of CED-4 with CED-3 and CED-9 $±$ a molecular framework for cell death. Science. 275, 1122–1126.
Chinnaiyan, A.M., O’rourke, K., Tewari, M. and Dixit, V.M. (1995). FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell. 81, 505–512.
Chinnaiyan, A.M., O’rourke, K., Yu, G.-L., Lyons, R.H., Garg, M., Duan, D.R., Xing, L., Gentz, R., Ni, J. and Dixit, V.M. (1996). Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science 274, 990–992.
Cho, Y., Gorina, S., Jeffrey, P.D., Pavletich, N.P. (1994). Crystal structure of a p53 tumour suppressor-DNA complex: understanding tumorigenic mutations. Science. 265, 346–355.
Cikala, M., Wilm, B., Hobmayer, E., Bottger, A. and David, C.N. (1999). Identification of caspases and apoptosis in the simple metazoan Hydra. Curr Biol. 9, 959–962.
Clarke, P.G.H. and Clarke, S. (1996). Nineteenth century research on naturally occurring cell death and related phenomena. Anat Embryol. 193, 81–99.
Cleary, M.L., Smith, S.D. and Sklar, J. (1986). Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell. 47, 19–28.
Clem, R.J., Fechheimer, M. and Miller, L.K. (1991). Prevention of apoptosis by a baculovirus gene during infection of insect cells. Science. 254, 1388–1390.
Cohen, J.J. and Duke, R.C. (1984). Glucocorticoid activation of calcium-dependent endonuclease in thymocyte nuclei leads to cell death. J Immunol. 132, 38–42.
Cohen, G.M., Sun, X.M., Fearnhea, H., Macfarlane, M., Brown, D.G., Snowden, R.T. and Dinsdale, D. (1994). Formation of large molecular weight fragments of DNA is a key committed step of apoptosis in thymocytes. J Immunol. 153, 507–516.
Conradt, B. and Horvitz, H.R. (1998). The C. elegans protein EGL-1 is required for programmed cell death and interacts with the Bcl-2-like protein CED-9. Cell. 93, 519–529.
Conway, E.M., Pollefeyt, S., steiner-Mosonyi, M., Luo, W., Devriese, A., Lupu, F., Bono, F., Leducq, N., Dol, F., Schaeffer, P., Collen, D. and Herbert, J.M. (2002). Deficiency of survivin in transgenic mice exacerbates Fas-induced apoptosis via mitochondrial pathways. Gastroenterology. 123, 619–631.
Cosman, D. (1994). A family of ligands for the TNF receptor superfamily. Stem Cells. 12,440–455.
Cossarizza, A., Kalashnikova, G., Grassilli, E., Chiappelli, F., Salvioli, S., Capri, M., Barbieri, D., Troiano, L., Monti, D. and Franceschi, C. (1994). Mitochondrial modifications during rat thymocyte apoptosis: a study at the single cell level. Exp Cell Res. 214, 323–330.
Coux, O., Tanaka, K. and Goldberg, A. L. (1996). Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem. 65, 801–847.
Cyrns, V. and Yuan, J. (1998). Proteases to die for. Genes Dev. 12, 1551–1570.
Decary, S., Decesse, J.T., Ogryzko, V., Reed, J.C., Naguibneva, I., Harel-Bellan, A. and Cremisi, C.E. (2002). The retinoblastoma protein binds the promoter of the survival gene bcl-2 and regulates its transcription in epithelial cells through transcription factor AP-2. Mol Cell Biol. 22, 7877–7888.
Deng, G. and Podack, E.R. (1995). Deoxyribonuclease induction in apoptotic cytotoxic T lymphocytes. FASEB J. 9, 665–669.
De Ruijter, A.J., Van Gennip, A.H., Caron, H.N., Kemp, S. and Van Kuilenburg, A.B. (2003). Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J. 370, 737–749. Review.
Deveraux, Q.L., Roy, N., Stennicke, H.R., VAN Arsdale, T., Zhou, Q., Srinivasula, S.M., Alnemri, E.S., Salvesen, G.S. and Reed, J.C. (1998). IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J. 17, 2215–2223.
Deveraux, Q., Takahashi, R., Salvesen, G.S. and Reed, J.C. (1997). X-linked IAP is a direct inhibitor of cell death proteases. Nature. 388, 300–303.
Devireddy, L.R. and Jones, C.J. (1999). Activation of caspases and p53 by bovine herpesvirus 1 infection results in programmed cell death and efficient virus release. J Virol. 73, 3778–3788.
Devita, V.T., Hellman, S. and Rosenberg, S.A. (2001). Cancer, Principles and Practice of Oncology (Lippincott-Raven, Philadelphia).
Di Gioacchino, M., Petrarca, C., Perrone, A., Martino, S., Esposito, D., Lotti, L.V., Mariani-Costantini, R. (2008). Autophagy in hematopoietic stem/progenitor cells exposed to heavy metals: biological implications and toxicological relevance. Autophagy. 4, 537–539.
Dobner, T., Horikoshi, N., Rubenwolf, S. and Shenk, T. (1996). Blockage by adenovirus E4orf6 of transcriptional activation by the p53 tumour suppressor. Science. 272, 1470–1473.
Donehower, L.A. and Bradley, A. (1993). The tumour suppressor p53. Biochim Biophys Acta. 23, 181–205.
Downward, J. (1999). How BAD phosphorylation is good for survival. Nature Cell Biol. 1, E 33–35.
Dubrez, L., Savoy, I., Hamman, A. and Solary, E. (1996). Pivotal role of a DEVD-sensitive step in etoposide-induced and Fas-mediated apoptotic pathways. EMBO J. 15, 5504–551.
Duckett, C.S., Nava, V.E., Gedrich, R.W., Clem, R.J., Vandongen, J.L., Gilfillan, M.C., Shiels, H., Hardwick, J.M. and Thompson, C.B. (1996). A conserved family of cellular genes related to the baculovirus IAP gene and encoding apoptosis inhibitors. EMBO J. 15, 2685–2694.
Duke, R.C. and Cohen, J.J. (1986). IL-2 addiction: withdrawal of growth factor activates a suicide program in dependent T cells. Lymphokine Res. 5, 289–299.
Durrieu, F., Samejima, K., Fortune, J., Kandels-Lewis, S., Osheroff, N. and Earnshaw, W. (2000). DNA topoisomerase IIa interacts with CAD nuclease and is involved in chromatin condensation during apoptotic execution. Curr Biol. 10, 923–926.
Earnshaw, W.C. (1995). Nuclear changes in apoptosis. Curr Opin Cell Biol. 7, 337–343.
Eastman, A. (1994). Deoxyribonuclease II in apoptosis and the significance of intracellular acidification. Cell Death Differ. 1, 7–10.
Ejercito, M. and Wolfe, J. (2004). Caspase-like activity is required for programmed nuclear elimination during conjugation in Tetrahymena. J Eukaryot Microbiol. 50, 427–429.
El-Deiry, W., Kern, S.E., Pietenpol, J.A., Kinzler, K.W. and Vogelstein B. (1992). Definition of a consensus binding site for p53. Nat Genet. 1, 45–49, 1992.
Ellis, H.M. and Horvitz, H.R. (1986). Genetic control of programmed cell death in the nematode C. elegans. Cell. 44, 817–829.
Enari, M., Hug, H. and Nagata, S. (1995). Involvement of an ICE-like protease in Fas mediated apoptosis. Nature 375, 78–81.
Enari, M., Sakahira, H., Yokoyama, H., Okawa, K., Iwamatsu, A. and Nagata, S. (1998). A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature. 391, 43–50.
Enari, M., Talanian, R.V., Wong, W.W. and Nagata, S. (1996). Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature 380, 723–726.
Evans, C.J. and Aguilera, R.J. (2003). DNase II: genes, enzymes and function. Gene. 322, 1–15.
Fadok, V.A., Bratton, D.L., Rose, D.M., Pearson, A., Ezekewitz, R.A. and Henson, P.M. (2000). A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature. 405, 85–90.
Fadok, V.A., Voelker, D.R., Campbell, P.A., Cohen, J.J., Bratton, D.L. and Henson, P.M. (1992). Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol. 148, 2207–2216.
Famulski, K.S., Macdonald, D., Paterson, M.C. and Sikora, E. (1999). Activation of a low pH-dependent nuclease by apoptotic agents. Cell Death Differ. 6, 281–289.
Fan, Z., Beresford, P.J., Oh, D.Y., Zhang, D. and Lieberman, J. (2003). Tumour suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor. Cell. 112, 659–672.
Fesus, L., Davies, P.J.A. and Piacentini, M. (1991). Apoptosis: molecular mechanisms in programmed cell death. Eur J Cell Biol. 56, 170–177.
Fesus, L., Madi, A., Balajthy, Z., Nemes, Z. and Szondy, Z. (1996). Transglutaminase induction by various cell death and apoptosis pathways. Experientia. 52, 942–949. Review.
Ford, J.M., Baron, E.L. and Hanawalt, P.C. (1998). Human fibroblasts expressing the human papillomavirus E6 gene are deficient in global genomic nucleotide excision repair and sensitive to ultraviolet irradiation. Cancer Res. 58, 599–603.
Fridman, J.S. and Lowe, S.W. (2003). Control of apoptosis by p53. Oncogene. 22, 9030–9040.
Friedberg, E.C., Walker, G.C., Siede, W., Wood, R.D., Schultz, R.A., Ellenberger, T. (2005). DNA Repair and Mutagenesis, 2nd edition. American Society for Microbiology Press, Washington DC, p. 1118.
Fritz, G., Grösch, S., Tomicic, M. and Kaina, B. (2003). APE/Ref-1 and the mammalian response to genotoxic stress. Toxicology. 193, 67–78.
Furukawa, Y., Nishimura, N., Furukawa, Y., Satoh, M., Endo, H., Iwase, S., Yamada, H., Matsuda, M., Kano, Y. and Nakamura, M. (2002). Apaf-1 is a mediator of E2F-1-induced apoptosis. J Biol Chem. 277, 39760–39768.
Ganesh, L., Yoshimoto, T., Moorthy, N.C., Akahata, W., Boehm, M., Nabel, E.G., Nabel, G.J. (2006). Protein methyltransferase 2 inhibits NF-kappaB function and promotes apoptosis. Mol Cell Biol. 26, 3864–3874.
Gannon, J.V., Greaves, R., Iggo, R. and Lane, D.P. (1990). Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. EMBO J. 9, 1595–1602.
Gannavaram, S., Vedvyas, C. and Debrabant, A. (2008). Conservation of the pro-apoptotic nuclease activity of endonuclease G in unicellular trypanosomatid parasites. J Cell Sci. 121, 99–109.
Garattini, E., Gianni, M. and Terao, M. (2004). Retinoid related molecules an emerging class of apoptotic agents with promising therapeutic potential in oncology: pharmacological activity and mechanisms of action. Curr Pharm Des. 10, 433–448. Review.
Garrido, C., Bruey, J.M., Fromentin, A., Hammann, A., Arrigo, A.P. and Solary, E. (1999). HSP27 inhibits cytochrome c-dependent activation of procaspase-9. FASEB J. 13, 2061–2070.
Genini, D., Sheeter, D., Rought, S., Zaunders, J.J., Susin, S.A., Kroemer, G., Richman, D.D., Carson, D.A., Corbeil, J., Leoni, L.M. (2001). HIV induces lymphocyte apoptosis by a p53-initiated, mitochondrial-mediated mechanism. FASEB J. 15, 5–6.
Gerace, L. and Blobel, G. (1980). The nuclear envelope lamina is reversibly depolymerized during mitosis. Cell. 19, 277–287.
Gil-Gómez, G. and Brady, H.J.M. (1998). Transgenic mice in apoptosis research. Apoptosis. 3, 215–228.
Ginaldi, L., De Martinis, M., Monti, D., Franceschi, C. (2005). Chronic antigenic load and apoptosis in immunosenescence. Trend Immunol. 26, 79–84.
Glickman, M.H. and Ciechanover, A. (2002). The ubiquitin–proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev. 82, 373–428.
Glucksmann, A. (1951). Cell deaths inn normal vertebrate ontogeny. Biol Rev. 26, 59–86.
Green, D.R. and Reed, J.R. (1998). Mitochondria and apoptosis. Science 281, 1309–1312.
Greenlund, L.J.S., Deckwerth, T.L. and Johnson, E.M.J. (1995). Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed cell death. Neuron. 14, 303–315.
Grether, M.E., Abrams, J.M., Agapite, J., White, K. and Steller, H. (1995). The head involution defective gene of Drosophila melanogaster functions in programmed cell death. Genes Dev. 9, 1694–1708.
Grover, P.L. (1979). In vitro modification of nucleic acids by direct-acting chemical carcinogens. In: Chemical Carcinogenesis and DNA, P.L. Grover, (ed). CRC, Boca Raton. FL. Vol. I, p. 37.
Hainaut, P. and Milner, J. (1992). Interaction of heat- shock protein 70 with p53 translated in vitro: evidence for interaction with dimeric p53 and for a role in the regulation of p53 conformation. EMBO J. 11, 3513–3520.
Halbert, D.N., Cutt, J.R. and Shenk, T. (1985). Adenovirus early region 4 encodes functions required for efficient DNA replication, late gene expression, and host cell shutoff. J Virol. 56, 250–257.
Halliwell, B. and Gutteridge, J.M. (1989). Free Radicals in Biology and Medicine (Clarendon Press, Oxford).
Hampton, M.B., Zhivotovsky, B., Slater, A.F., Burgess, D.H. and Orrenius, S. (1998). Importance of the redox state of cytochrome c during caspase activation in cytosolic extracts. Biochem J. 329, 95–99.
Hanayama, R., Tanaka, M., Miyasaka, K., Aozasa, K., Koike, M. Uchiyama, Y. and Nagata, S. (2004). Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science. 304, 1147–1150.
Harlow, E., Crawford, L.V., Pim, D.C. and Williamson, N.M. (1981). Monoclonal antibodies specific for simian virus 40 tumour antigen. J Virol. 39, 861–869.
Harris, C.C., (1996). P53 Tumour suppressor gene: from the basic research to laboratory to the clinican abridged historical perspective. Carcinogenesis 17, 1187–1198.
Harris, C.C. and Hollstein, M. (1993). Clinical implications of the p53 tumour-suppressor gene. N Engl J Med. 329, 1318–1327.
Harris, S.L. and Levine, A.J. (2005). The p53 pathway: positive and negative feedback loops. Oncogene. 24, 2899–2908.
Haupt, Y., Maya, R., Kazaz, A. and Oren, M. (1997). Mdm2 promotes the rapid degradation of p53. Nature. 387, 296–299.
Haupt, Y., Rowan, S., Shaulian, E., Vousden, K.H. and Oren, M. (1995). Induction of apoptosis in HeLa cells by transactivation-deficient p53. Genes Dev. 9, 2170–2133.
Harvey, D.M. and Levine, A.J. (1991). p53 alteration is a common event in the spontaneous immortalization of primary BALB/c murine embryo fibroblasts. Genes Dev. 5, 2375–85.
Havel, A., Durzan, D.J. Strnad, M., Pec, P. and Beck, E. (eds). (1999). Programmed cell death in plant development. In Advances in Regulation of Plant Growth and Development. Peres Publisher, Prague, pp. 119–212.
Hawley-Nelson, P., Vousden, K.H., Hubbert, N.L., Lowy, D.R. and Schiller, J.T. (1989). HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J. 8,
Hay, B.A., Wassarman, D.A. and Rubin, G.M. (1995). Drosophila homologs of baculovirus inhibitor of apoptosis proteins function to block cell death. Cell. 83, 1253–1262.
He, X., Zhang, Q., Liu, Y. and He, P. (2005). Apoptin induces chromatin condensation in normal cells. Virus Genes. 31, 49–55.
He, J., Tohyama, Y., Yamamoto, K., Kobayashi, M., Shi, Y., Takano, T., Noda, C., Tohyama, K. and Yamamura, H. (2005). Lysosome is a primary organelle in B cell receptor-mediated apoptosis: an indispensable role of Syk in lysosomal function. Genes Cells. 10, 23–35.
Hedgecock, E.M., Sulston, J.E. and Thomson, J.N. (1983). Mutations affecting programmed cell deaths in the nematode Caenorhabditis elegans. Science 220, 1277–1279.
Helt, A.-M. and Galloway, D.A. (2003). Mechanisms by which DNA tumour virus oncoproteins target the Rb family of pocket proteins. Carcinogenesis 24, 159–169.
Hengartner, M.O. (2001). Apoptosis DNA destroyers. Nature. 412, 27–29.
Hengartner, M.O., Ellis, R.E. and Horvitz, H.R. (1992). Caenorhabditis elegans gene ced-9 protects cells from programmed cell death. Nature 356, 494–499.
Hetz, C.A., Hunn, M., Rohas, P., Torres, V., Leyton, L. and Quest, A.F.G. (2002). Caspase-dependent initiation of apoptosis and necrosis by the Fas receptor in lymphoid cells: onset of necrosis is associated with delayed ceramide increase. J Cell Sci. 115, 4671–4683.
Hewish, D.R. and Burgoyne, L.A. (1973). Chromatin sub-structure. The digestion of chromatin DNA at regularly spaced sites by a nuclear deoxyribonuclease. Biochem Biophys Res Comm. 52, 504–510.
Higami, Y., To, K., Ohtani, H., Masui, K., Iwasaki, K., Shiokawa, D. Tanuma, S. and Shimokawa, I. (2003). Involvement of DNase g in apoptotic DNA fragmentation in histiocytic necrotizing lymphadenitis. Virchows Arch. 443, 170–174.
Hilt, W. and Wolf, D. H. (1996). Proteasomes: destruction as a programme. Trends Biochem Sci. 21, 96–102
Hinds, P.W., Finlay. C.A., Frey, A.B. and Levine, A.J. (1987). Immunological evidence for the association of p53 with a heat shock protein, hsc70, in p53-plus-ras-transformed cell lines. Mol Cell Biol. 7, 2863–2869.
Hirao, A., Kong, Y.Y., Matsuoka, S., Wakeham, A., Ruland, J., Yoshida, H., Liu, D., Elledge, S.J. and Mak, T.W. (2000). DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science. 287, 1824–1827.
Hockenbery, D.M., Oltvai, Z.N., Yin, X.-M., Milliman, C.L. and Korsmeyer, S.J. (1993). Bcl-2 functions in an anti-oxidant pathway. Cell 75, 241–251.
Hoffmann, H., Högel, J. and Speit, G. (2005). The effect of smoking on DNA effects in the comet assay: a meta-analysis. Mutagenesis. 20, 455–466.
Hofmann, K., Bucher, P. and Tschopp, J. (1997). The CARD domain – a new apoptotic signalling motif. Trends Biochem Sci. 22, 155–156.
Holler, N., Zaru, R., Micheau, O., Thome, M., Attinger, A., Valitutti, S., Bodmer, J.L., Schneider, P., Seed, B. and Tschopp, J. (2000). Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol. 1, 489–495.
Hollstein, M., Rice, K., Greenblatt, M.S., Soussi, T., Fuchs, R., Sorlie, T., Hovig, E., Smith-Sorensen, B., Montesano, R. and Harris, C.C. (1994). Database of p53 gene somatic mutations in human tumours and cell lines. Nucleic Acids Res. 22, 3551–3555.
Hong, M.Y., Chapkin, R.S., Wild, C.P., Morris, J.S., Wang, N., Carroll, R.J., Turner, N.D. and Lupton, J.R. (1999). Relationship between DNA adduct levels, repair enzyme, and apoptosis as a function of DNA methylation by azoxymethane. Cell Growth Differ. 10, 749–758.
Horvitz, H.R., Ellis, H.M. and Sternberg, P.W. (1982). Programmed cell death in nematode development. Neurosci Comment. 1, 56–65.
Hotchkiss, R.S., Swanson, P.E., Knudson, C.M., Chang, K.C., Cobb, J.P., Osborne, D.F., Zollner, K.M., Buchman, T.G., Korsmeyer, S.J. and Karl, I.E. (1999). Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis. J Immunol. 162, 4148–4156.
Huang, X., Tran, T., Zhang, L., Hatcher, R. and Zhang, P. (2005). DNA damage-induced mitotic catastrophe is mediated by the Chk1-dependent mitotic exit DNA damage checkpoint. Proc Natl Acad Sci. USA 102, 1065–1070.
Hughes, F.M. Jr., Cidlowski, J.A. (1997). Utilization of an in vitro apoptosis assay to evaluate chromatin degradation by candidate apoptotic nucleases. Cell Death Differ. 4, 200–208.
Hughes, F.M.JR1., Evans-Storms, R.B. and Cidlowski, J.A. (1998). Evidence that non-caspase proteases are required for chromatin degradation during apoptosis. Cell Death Differ. 5, 1017–1027.
Hwang, B.J., Ford, J.M., Hanawalt, P.C. and Chu, G. (1999). Expression of the p48 xeroderma pigmentosum gene is p53-dependent and is involved in global genomic repair. Proc Natl Acad Sci USA 96, 424–428.
Irmler, M., Hofmann, K., Vaux, D.L. and Tschopp, J. (1997). Direct physical interaction between the Caenorhabditis elegans death proteins CED-3 and CED-4. FEBS Lett. 406, 189–190.
Isaacs, J.S., Hardman, R., Carman, T.A., Barrett, J.C. and Weissman, B.E. (1998). Differential subcellular p53 localization and function in N- and S-type neuroblastoma cell lines. Cell Growth Differ. 9, 545–555.
Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S., Sameshima, M., Hase, A., Seto, Y. and Nagata, S. (1991). The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell. 66, 233–243.
Jacobs-Helber, S.M., Wickrema, A., Birrer, M.J. and Sawyer, S.T. (1998). AP1 regulation of proliferation and initiation of apoptosis in erythropoietin-dependent erythroid cells. Mol Cell Biol. 18, 3699–3707.
Jacobson, M.D., Burne, J.F., King, M.P., Miyashita, T., Reed, J.C. and Raff, M.C. (1993). Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature. 361, 365–369.
Jacobson, M.D., Weil, M. and Raff, M.C. (1996). Role of Ced-3/ICE-family of proteases in staurosporine-induced programmed cell death. J Cell Biol. 133, 1041–1051.
Jacobson, M.D., Weil, M. and Raff, MC. (1997). Programmed cell death in animal development. Cell.88, 347–54. Review.
James, C., Gschmeissner, S., Fraser, A. and Evan, G.I. (1997). CED-4 induces chromatin condensation in Schizosaccharomyces pombe and is inhibited bydirect physical association with CED-9. Curr Biol. 7, 246–252.
Jentsch, S. (1992). Ubiquitin-dependent protein degradation: a cellular perspective. Trends Cell Biol. 2, 93–103.
Jenuwein, T. and Allis, C.D. (2001). Translating the “histone code”. Science 293, 1074–1080.
Jimenez, B., Volpert, O.V., Crawford, S.E., Febbraio, M., Silberstein, R.L. and Bouck, N. (2000). Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nature Med. 6, 41–48.
Johnson, N.L., Gardner, A.M., Diener, KM., Lange-Carter, C.A., Gleavy, J., Jarpe, M.B., Minden, A., Karin, M., Zon, L.I. and Johnson, G.L. (1996). Signal transduction pathways regulated by mitogen-activated/extracellular response kinase kinase kinase induce cell death. J Biol Chem. 271, 3229–3237.
Kagi, D., Ledermann, B., Burki, K., Seiler, P., Odermatt, B., Olsen, K.J., Podack, E.R., Zinkernagel, R.M. and Hengartner, H. (1994). Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature. 369, 1–37.
Kanai, Y. (2003). The role of non-chromosomal histones in the host defense system. Microbiol Immunol. 47, 553–556.
Kane, D.J., Sarafin, T.A., Anton, R., Hahn, H., Gralla, E.B., Valentine, J.S., Örd, T. and Bredesen, D.E. (1993). Bcl-2 inhibition of neuronal death: decreased generation of reactive oxygen species. Science. 262, 1274–1277.
Karran, P. and Bignami, M. (1999). in DNA Recombination and Repair. Smith, P. J. and Jones, C. J. (eds) (Oxford Univ. Press, New York), pp. 66–159.
Kaufmann, S.H. (1989). Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note. Cancer Res. 49, 5870–5878.
Kaufmann, S., Desnoyers, S., Ottaviano, Y., Davidson, N. and Poirier, G.G. (1993). Specific proteolytic cleavage of poly(ADP-ribose)polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res. 53, 3976–3985.
Kelekar, A. and Thompson, C.B. (1998). Bcl-2 family proteins: The role of the BH-3 domain in apoptosis. Trends Cell Biol. 8, 324–330.
Kerr, J. (1965). A histochemical study of hypertrophy and ischaemic injury of ratliver with special reference to changes in lysosomes. J Pathol Bacteriol. 90, 419–435.
Kerr, J.F.R. (1971). Shrinkage necrosis: a distinct mode of cellular death. J Pathol. 105, 13–20.
Kerr, J.F., Wyllie, A.H. and Currie, A.R. (1972). Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 26, 239–257.
Kharbanda, S., Pandey, P., Schofield, L., Israels, S., Roncinske, R., Yoshida, K., Bharti, A. Yuan, Z.-M., Saxena, S., Weichselbaum, R., Nalin, C. and Kufe, D. (1997). Role for Bcl-xL as an inhibitor of cytosolic cytochrome c accumulation in DNA damage-induced apoptosis. Proc Natl Acad Sci USA. 94, 6939–6942.
Khodarev, N.N. and Ashwell, J.D. (1996). An inducible lymphocyte nuclear Ca2+/Mg2+- dependent endonuclease associated with apoptosis. J Immunol. 156, 922–931.
Kihlmark, M., Imreh, G. and Hallberg, E. (2001). Sequential degradation of proteins from the nuclear envelope during apoptosis. J. Cell Sci. 114, 3643–3653.
Kim, B.E., Roh, S.R., Kim, J.W., Jeong, S.W. and Kim, I.K. (2003). Cytochrome c-dependent Fas-independent apoptotic pathway in HeLa cells induced by delta12-prostaglandin J2. Exp Mol Med. 35, 290–300.
Kim, C.N., Wang, X., Huang, Y., Ibrado, A.M., Liu, L., Fang, G. and Bhalla, K. (1997). Overexpression of Bcl-xL inhibits Ara-c-induced mitochondrial loss of cytochrome c and other perturbations that activate the molecular cascade of apoptosis. Cancer Res. 57, 3115–3120.
Kitson, J., Raven, T., Jiang, Y.-P., Goeddel, D.V., Giles, K.M., Pun, K.T., Grinham, C.J., Brown, R. and Farrow, S.N. (1996). A death-domain-containing receptor that mediates apoptosis. Nature. 384, 372–375.
Klein, J.A., Longo-Guess, C.M., Rossmann, M.P., Seburn, K.L., Hurd, R.E., Frankel, W.N., Bronson, R.T. and Ackerman, S.L. (2002). The harlequin mouse mutation downregulates apoptosis-inducing factor. Nature. 419, 367–374.
Kluck, R.M., Bossy-Wetzel, E., Green, D.R. and Newmeyer, D.D. (1997). The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275, 1132–1136,.
Kluck, R.M., Martin, S.J., Hoffman, B.M., Zhou, J.S., Green, D.R. and Newmeyer, D.D. (1997). Cytochrome c activation of CPP32-like proteolysis plays a critical role in a Xenopus cell-free apoptosis system. EMBO J. 16, 4639–4649.
Koken, M.H.M., Hoogerbrugge, J.M., Jaspers-Dekker, L., De Wit, J., Willemsen, R., Roest, H.P., Grootegoed, J.A. and Hoeijmakers, J.H.J. (1996). Expression of ubiquitin-conjugation DNA repair enzyme HHR6A and B suggests a role in spermatogenesis and chromatin modification. Dev Biol. 173, 119–132.
Konat, G.W. (2003). $H2O2$-induced higher order chromatin degradation: A novel mechanism of oxidative genotoxicity. J Biosci. 28, 57–60.
Kolter, R. (2007). Deadly priming. Science. 318, 578–579.
Koumenis, C., Alarcon, R., Hammond, E., Sutphin, P., Hoffman, W., Murphy, M., Derr, J., Taya, Y., Lowe, S.W., Kastan, M. and Giaccia, A. (2001). Regulation of p53 by hypoxia: dissociation of transcriptional repression and apoptosis from p53-dependent transactivation. Mol Cell Biol. 21, 1297–1310.
Kouzarides, T. (2007). Chromatin modifications and their function. Cell 128, 693–705.
Kreuder, V., Dieckhoff, J., Sittig, M. and Mannherz, H.G. (1984). Isolation, characterization and crystallization of deoxyribonuclease I from bovine and rat parotid gland and its interaction with rabbit skeletal muscle actin. Eur J Biochem. 139, 389–400.
Krieser, R.J. and Eastman, A. (1998). The cloning and expression of human deoxyribonuclease II. A possible role in apoptosis. J Biol Chem. 273, 30909–30914.
Kroemer, G. and Martin, S.J. (2005). Caspase-independent cell death. Nat Med. 11, 725–730.
Kubbutat, M.H., Jones, S.N. and Vousden, K.H. (1997). Regulation of p53 stability by Mdm2. Nature. 387, 299–303.
Lagarkova, M.A., Iarovaia, O.V. and Razin, S.V. (1995). Large scale fragmentation of mammalian DNA in the course of apoptosis procedes via excision of chromosomal DNA loops and their oligomers. J Biol Chem. 270, 20239–20245.
Lane, D.P. (1984). Cell immortalization and transformation by the p53 gene. Nature. 312, 596–597.
Lane, D.P. (1992). Cancer p53, guardian of the genome. Nature. 358, 15–16.
Laster, S.M., Wood, J.G. and Gooding, L.R. (1988). Tumour necrosis factor can induce both apoptotic and necrotic cell lysis. J Immunol. 141, 2629–2634.
Lazebnik, Y.A., Takahasi, A., Poirier, G.G., Kaufmann, S.H. and Earnshaw, W.C. (1995). Characterization of the execution phase of apoptosis in vitro using extracts from condemned-phase cells. J Cell Sci Suppl. 19, 41M9.
Lee, J.H. and Paull, T.T. (2004). Direct activation of the ATM protein kinase by the Mre11/Rad50/Nbs1 complex. Science. 304, 93–96.
Lee, J.H. and Paull, T.T. (2005). ATM activation by DNA double-strand breaks through the Mre11-Rad50-Nbs1 complex. Science. 308, 551–554.
Lee, Y. S. Jang, M. S. Lee, J. S. Choi, E. J. and Kim, E. (2005). SUMO-1 represses apoptosis signal-regulating kinase 1 activation through physical interaction and not through covalent modification. EMBO Rep. 6, 949–955.
Leist, M. and Jaattela, M. (2001). Four death and a funeral: From caspases to alternative mechanisms. Nat Rev Mol Cell Biol. 2, 589–598.
Letai, A., Bassik, M.C., Walensky, L.D., Sorcinelli, M.D., Weiler, S. and Korsmeyer, S.J. (2002). Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell. 2, 183–192.
Levine, A.J. (1997). p53, the cellular gatekeeper for growth and division. Cell. 88, 323–331.
Li, F., Srinivasan, A., Wang, Y., Armstrong, R.C., Tomaselli, K.J. and Fritz, L.C. (1997). Cell-specific induction of apoptosis by microinjection of cytochrome c. J Biol Chem. 272, 30299–30305.
Li, H., Zhu, H., Xu, C.J. and Yuan, J. (1998). Cleavage of BID by Caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell. 94, 491–501.
Li, L.Y., Luo, X. and Wang, X. (2001). Endonuclease G is an apoptotic DNase when released from mitochondria. Nature. 412, 95–99.
Liebermann, D.A., Hoffman, B. and Steinman, R.A. (1995). Molecular controls of growth arrest and apoptosis: p53-dependent and independent pathways. Oncogene. 11, 199–210.
Liedberg, B., Nylander, C.I. and Lundstrom, L. (1983). Surface plasmon resonance for gas detection and biosensing. Sens Actuators B Chem. 4, 299–304.
Linzer, D.I. and Levin, A.J. (1979). Characterization of a 54K dalton cellular SV40 tumour antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell. 17, 43–52.
Lyon, C.J., Evans, C.J., Bill, B.R., Otsuka, A.J. and Aguilera, R.J. (2000). The C. elegans apoptotic nuclease NUC-1 is related in sequence and activity to mammalian DNase II. Gene. 252,
Lipton, S.A. and Bossy-Wetzel, E. (2002). Dueling activities of AIF in cell death versus survival: DNA binding and redox activity. Cell. 111, 147–150.
Liston, P., Roy, N., Tamai, K., Lefebvre, C., Baird, S., Chertonhorvat, G., Farahani, R., Mclean, M., Ikeda, J.E., Mackenzie, A. and Korneluk, R.G. (1996). Suppression of apoptosis inmammalian cells by NAIP and a related family of IAP genes. Nature 379, 349–353.
Liu, X., Li, P., Widlak, P., Zou, H., Luo, X., Garrard, W.T. and Wang, X. (1998). The 40-kDa subunit of DNA fragmentation factor induces DNA fragmentation and chromatin condensation during apoptosis. Proc Natl Acad Sci USA 95, 8461–8466.
Liu, X., Kim, C.N., Yang, J., Jemmerson, R. and Wang, X. (1996). Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell. 86, 147–157.
Liu, X., Zou, H., Slaughter, C. and Wang, X. (1997). DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell. 89, 175–184.
Liu, X., Zou, H., Widlak, P., Garrard, W. and Wang, X. (1999). Activation of the apoptotic endonuclease DFF40 (caspase-activated DNase or nuclease). Oligomerization and direct interaction with histone H1. J Biol Chem. 274, 13836–13840.
Lloyd, D.R. and Hanawalt, P.C. (2000). p53-dependent global genomic repair of benzo[a]pyrene-7,8-diol-9,10-epoxide adducts in human cells. Cancer Res. 60, 517–521.
Lockshin, R.A. and Williams, C.M. (1964). Programmed cell death. II. Endocrine potentiation of the breakdown of the intersegmental muscles of silkmoths. J Insect Physiol. 10, 643–649.
Lotem, J. and Sachs, L. (1998). Different mechanisms for suppression of apoptosis by cytokines and calcium mobilizing compounds. Proc Natl Acad Sci USA. 95, 4601–4606.
Lotem, J. and Sachs, L. (1999). Cytokines as suppressors of apoptosis. Apoptosis 4, 187–196.
Lynch, D.H., Ramsdell, F. and Alderson, M.R. (1995). Fas and FasL in thehomeostatic regulation of immune responses. Immunol Today. 16, 569–574.
Majno, G., Joris, I. (1995). Apoptosis, oncosis and necrosis: An overview of cell death. Am J Pathol. 146, 3–15.
Marsters, S.A., Pitti, R.M., Donahue, C.J., Ruppert, S., Bauer, K.D. and Ashkenazi, A. (1996a). Activation of apoptosis by Apo-2 ligand is independent of FADD but blocked by CrmA. Curr Biol. 6, 750–752.
Marsters, S.A., Sheridan, J.P., Donahue, C.J., Pitti, R.M., Gray, C.L., Goddard, A.D., Bauer, K.D. and Ashkenazi, A. (1996b). Apo-3, a new member of tumour necrosis factor receptor family, contains a death domain and activates apoptosis and NF-kB. Curr Biol. 6, 1669–1676.
Marsters, S.A., Sheridan, J.P., Pitti, R.M., Brush, J., Goddard, A. and Ashkenazi, A. (1998). Identification of a ligand for the death-domain containing receptor Apo3. Curr Biol. 8, 525–528.
Martinou, I., Desagher, S., Eskes, R., Antonsson, B., Andre, E., Fakan, S. and Martinou, J-C. (1999). The release of cytochrome c from mitochondria during apoptosis of NGF-deprived sympathetic neurons is a reversible event. J Biol Chem. 144, 883–889.
Martins, L.M. and Earnshaw, W.C. (1997). Apoptosis: alive and kicking in 1997. Trends Cell Biol. 7, 111–14.
Matwee, C., Betts, D.H. and King, W.A. (2000). Apoptosis in the early bovine embryo. Zygote. 8, 57–68.
Mccarthy, S.A., Symonds, H.S. and Van Dyke, T. (1994). Regulation of apoptosis in transgenic mice by simian virus 40 T antigen-mediated inactivation of p53. Proc Natl Acad Sci USA. 91, 3979–3983.
Mccarthy, S. and Ward, W.S. (1999). Functional aspects of mammalian sperm chromatin. Hum Fertil (Camb). 2, 56–60.
Metz, T., Harris, A.W. and Adams, J.M. (1995). Absence of p53 allows direct immortalization of hematopoietic cells by the myc and raf oncogenes. Cell. 82, 29–36.
Mihara, M., Erster, S., Zaika, A., Petrenko, O., Chittenden, T., Pancoska, P. and Moll, U.M. (2003). p53 has a direct apoptotic role at the mitochondria. Mol Cell. 11, 577–590.
Miura, M., Zhu, H., Rotello, R., Hartweige, A. and Yuan, J. (1993). Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell. 75, 653–660.
Miura, O., D’andrea, A., Kabat, D. and Ihle, J.N. (1991). Induction of tyrosine phosphorylation by the erythropoietin receptor correlates with mitogenesis. Mol Cell Biol. 11, 4895–4902.
Moll, U.M., Riou, G. and Levine, A.J. (1992). Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. Proc Natl Acad Sci USA. 89, 7262–7266.
Moller, P., Knudsen, L.E., Loft, S. and Wallin, H. (2000). The comet assay as a rapid test in biomonitoring occupational exposure to DNA-damaging agents and effect of confounding factors. Cancer Epidem Biomar Prevent 9, 1005–1015.
Montague, J.W., Hughes, F.M. Jr. and Cidlowski, J.A. (1997). Native recombinant cyclophilins A, B, and C degrade DNA independently of peptidylprolyl cis-trans isomerase activity: Potential roles of cyclophilins in apoptosis. J Biol Chem. 272, 6677–6684.
Moore, M., Horikoshi, N. and Shenk, T. (1996). Oncogenic potential of the adenovirus E4orf6 protein. Proc Natl Acad Sci USA. 93, 11295–11301.
Moore, R.M., Silver, R.J. and Moore, J.J. (2003). Physiological apoptotic agents have different effects upon human amnion epithelial and mesenchymal cells. Placenta. 24, 173–180.
Moos, P.J., Edes, K. and Fitzpatrick, F.A. (2000). Inactivation of wild-type p53 tumour suppressor by electrophilic prostaglandins. Proc Natl Acad Sci USA. 97, 9215–9220.
Mora, P.T.K., Chandrashekaran, K., Hoffman, J.C. and Mcfarland, V.W. (1982). Quantitation of 55K cellular protein: similar amount and instability in normal and malignant mouse cells. Mol Cell Biol. 2, 763–771.
Motyl, T., Grzelkowska, K., Zimowska, W., Skierski, J., Wareski, P., Płoszaj, T. and Trzeciak, L. (1998). Expression of bcl-2 and bax in TGF-beta 1-induced apoptosis of L1210 leukemic cells. Eur J Cell Biol. 75, 367–74.
Muchmore, S.W., Sattler, M., Liang, H., Meadows, R.P., Harlan, J.E., Yoon, H.S., Nettesheim, D., Chang, B.S., Thompson, C.B., Wong, S.L., Ng, S.-C. and Fesik, S.W. (1996). X-ray and NMR structure of human Bcl-x(1), an inhibitor of programmed cell death. Nature 381, 335–341.
Mukhopadhyay, T. and Roth, J.A. (1997). Induction of apoptosis in human lung cancer cells after wild-type p53 activation by methoxyestradiol. Oncogene. 14, 379–384.
Muzio, M., Chinnaiyan, A.M., Kischkel, F.C., O’rourke, K., Shevchenko, A., Ni, J., Scaffidi, C., Bretz, J.D., Zhang, M., Ni, R.J., Gentz, R., Mann, M., Krammer, P.H., Peter, M.E. and Dixit, V.M. (1996). FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death–inducing signaling complex. Cell. 85, 817–827.
Nagata, S. and Golstein, P. (1995). The Fas death factor. Science. 267, 1449–1456.
Neame, S.J., Rubin, L.L. and Philpott, K.L. (1998). Blocking cytochrome c activity within intact neurons inhibits apoptosis. J Cell Biol. 142, 1583–1593.
Nevels, M., Rubenwolf, S., Spruss, T., Wolf, H. and Dobner, T. (1997.). The adenovirus E4orf6 protein can promote E1A/E1B-induced focus formation by interfering with p53 tumour suppressor function. Proc Natl Acad Sci USA. 94, 1206–1211.
Nezis, I.P., Stravopodis, D.J., Papassideri, I., ROBERT-Nicoud, M. and Margaritis, L.H. (2000). Stage-specific apoptotic patterns during Drosophila oogenesis. Eur J Cell Biol. 79, 610–620.
Nicholson, D.W. (1996). ICE/CED3-like proteases as therapeutic targets for the control of inappropriate apoptosis. Nat Biotechnol. 14, 297–301. Review.
Nicholson, D. W. (1999). Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ. 6, 1028–1042.
Nicholson, D.W., Ali, A., Thornberry, N.A., Vaillancourt, J.P., Ding, C.K., Gallant, M., Gareau, Y., Griffin, P.R., Labelle, M., Lazebnik, Y.A., Munday, N.A., Raju, S.M., Smulson, M.E., Yamin, T.-T., Yu, V.L. and Miller, D.K. (1995). Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 376, 37–43.
Nijhawan, D., Honarpour, N. and Wang, X. (2000). Apoptosis in neural development and disease. Annu Rev Neurosci. 23, 73–87. Review.
Nishimura, K., Tsumagari, H., Morioka, A., Yamauchi, Y., Miyashita, K., Lu, S., Jisaka, M., Nagaya, T. and Yokota, K. (2002). Regulation of apoptosis through arachidonate cascade in mammalian cells. Appl Biochem Biotechnol. 102–103, 239–250.
Norbury, C.J. and Zhivotovsky, B. (2004). DNA damage-induced apoptosis. Oncogene. 23, 2797–2808.
Nurse, P. (1990). Universal control mechanism regulating onset of M-phase. Nature. 344, 503–508.
Oberhammer, F., Fritsch, G., Schmied, M., Pavelka, M., Printz, D., Purchio, T., Lassmann, H. and Schulte-Hermann, R. (1993). Condensation of the chromatin at the nuclear membrane o fan apoptotic nucleus is not associated with activation o fan endonuclease. J Cell Sci. 104, 317–326.
Oberhammer, F., Wilson, J.W., Dive, C., Morris, I.D., Hickman, J.A., Wakeling, A.E., Walker, P.R. and Sikorska, M. (1993). Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation; EMBO J. 12, 3679–3684.
Odake, S., Kam, C.M., Narasimhan, L., Poe, M., Blake, J.T., Krahenbuhl, O., Tschopp, J. and Powers, J.C. (1991). Human and murine cytotoxic T lymphocyte serine proteases: subsite mapping with peptide thioester substrates and inhibition of enzyme activity and cytolysis by isocoumarins. Biochemistry 30, 2217–2227.
Offer, H., Zurer, I., Bánfalvi, G., Rehak, M., Falcovitz, A., Milyavsky, M., Goldfinger, N. and Rotter, V. (2001). p53 modulates base excision activity in a cell cycle-specific manner after genotoxic stress. Cancer Res. 61, 88–96.
Ogawara, Y., Kishishita, S., Obata, T., Isazawa, Y., Suzuki, T., Tanaka, K., Masuyama, N. and Gotoh, Y. (2002). Akt enhances Mdm2-mediated ubiquitination and degradation of p53. J Biol Chem. 277, 21843–21850.
Okuno, S., Shimizu, S., Ito, T., Nomura, M., Hamada, E., Tsujimoto, Y. and Matsuda, H. (1998). Bcl-2 prevents caspase-independent cell death. J Biol Chem. 273, 34272–34277.
Oliverio, S., Amendola, A., DI Sano, F., Farrace, M.G., Fesus, L., Nemes, Z., Piredda, L., Spinedi, A. and Piacentini, M. (1997). Tissue transglutaminase-dependent posttranslational modification of the retinoblastoma gene product in promonocytic cells undergoing apoptosis. Mol Cell Biol. 17, 6040–6048.
Oltvai, Z.N., Milliman, C.L. and Korsmeyer, S.J. (1993). Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 74, 609–619.
Opitz, O.G., Suliman, Y., Hahn, W.C., Harada, H., Blum, H.E., Rustgi, A.K. (2001). Cyclin D1 overexpression and p53 inactivation immortalize primary oral keratinocytes by a telomerase-independent mechanism. J Clin Invest. 108, 725–732.
Oppermann, M., Geilen, C.C., Fecker, L.F., Gillissen, B., Daniel, P.T. and Eberle, J. (2005). Caspase-independent induction of apoptosis in human melanoma cells by the proapoptotic Bcl-2-related protein Nbk / Bik. Oncogene.24, 7369–7380.
Oren, M., Maltzman, W. and Levine, A.J. (1981). Post-translational regulation of the 54K cellular tumour antigen in normal and transformed cells. Mol Cell Biol. 1, 101–110.
Oren, M. and Rotter, V.(1999). Introduction: p53 – the first twenty years. Cell Mol Life Sci. 55, 9–11.
Ottilie, S., Wang, Y., Banks, S., Chang, J., Vigna, N.J., Weeks, S., Armstrong, R.C., Fritz, L.C. and Oltersdorf, T. (1997). Mutational analysis of the interacting cell death regulators CED-9 and CED-4. Cell Death Differ. 4, 526–533.
Pandey, S., Smith, B., Walker, P.R. and Sikorska, M. (2000). Caspase-dependent and independent cell death in rat hepatoma 5123tc cells. Apoptosis.5, 265–75.
Pandey, S., Walker, P.R. and Sikorska, M. (1994). Separate pools of endonuclease activity are responsible for internucleosomal and high molecular mass DNA fragmentation during apoptosis. Biochem Cell Biol. 72, 625–629.
Pandey, S., Walker, P.R. and Sikorska, M. (1997). Identification of a novel 97 kDa endonuclease capable of internucleosomal DNA cleavage. Biochem. 36, 711–720.
Parant, J.M. and Lozano, G. (2003). Disrupting TP53 in mouse models of human cancers. Hum Mutat. 21, 321–326.
Parrish, J., Li, L., Klotz, K., Ledwich, D., Wang, X. and Xue, D. (2001). Mitochondrial endonuclease G is important for apoptosis in C. elegans. Nature 412, 90–94.
Peitsch, M.C., Polzar, B., Stephan, H., Crompton, T., Macdonald, H.R., Mannherz, H.G. and Tschoop, J. (1993). Characterization of the endogenous deoxyribonuclease involved in nuclear DNA degradation during apoptosis (programmed cell death). EMBO J. 12, 371–377.
Peitsch, M.C., Polzar, B., Tschopp, J. and Mannherz, H.G. (1994). About the involvement of deoxyribonuclease I in apoptosis. Cell Death Differ. 1, 1–6.
Peter, M., Nakagawa, J., Doree, M., Labbe, C. and Nigg, E.A. (1990). In vitro disassembly of nuclear lamina by cdc2 kinase. Cell. 61, 591–602.
Petit, P.X., Lecoeur, H., Zorn, E., Dauguet, C., Mignotte, B. and Gougeon, M.-L. (1995). Alterations in mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis. J Cell Biol. 130, 157–167.
Petit, P.X., Susin, S-A., Zamzami, N., Mignotte, B. and Kroemer, G. (1996). Mitochondria and programmed cell death: back to the future. FEBS Lett. 396, 7–13.
Philpott, K.L., Mccarthy, M.J., Becker, D., Gatchalian, C. and Rubin, L.L. (1996). Morphological and biochemical changes in neurons: apoptosis versus mitosis. Eur J Neurosci. 8(9), 1906–15.
Pilder, S., Moore, M., Logan, J. and Shenk, T. (1986). The adenovirus E1B-55K transforming polypeptide modulates transport or cytoplasmic stabilization of viral and host cell mRNAs. Mol Cell Biol. 6, 470–476
Pitti, R.M., Marsters, S.A., Ruppert, S., Donahue, C.J., Moore, A. and Ashkenazi, A. (1996). Induction of apoptosis by Apo-2 ligand, a new member of the tumour necrosis factor cytokine family. J Biol Chem. 271, 12687–12690.
Plymale, D.R., Tang, D.S., Comardelle, A.M., Fermin, C.D., Lewis, D.E. and Garry, R.F. (1999). Both necrosis and apoptosis contribute to HIV-1-induced killing of CD4 cells. AIDS. 13, 1827–1839.
Poe, M., Blake, J.T., Boulton, D.A., Gammon, M., Sigal, N.H., Wu, J.K. and Zweerink, H.J. (1991). Human cytotoxic lymphocyte granzyme B. Its purification from granules and the characterization of substrate and inhibitor specificity. J Biol Chem. 266, 98–103.
Polyak, K., Xia, Y., Zweier, J.L., Kinzler, K.W. and Vogestein, B. (1997). A model for p53-induced apoptosis. Nature. 389, 300–305.
Polzar, B., Zanotti, S., Stephan, H., Rauch, E., Peitsch, M.C., Irlmer, M., Tschopp, J. and Mannherz, H.G. (1994). Distribution of deoxyribonuclease I in rat tissues and its correlation to cellular turnover and apoptosis (programmed cell death). Eur J Cell Biol. 64, 200–210.
Portis, T., Grossman, W.J., Harding, J.C., Hess, J.L. and Ratner, L. (2001). Analysis of p53 inactivation in a human T-cell leukemia virus type 1 Tax transgenic mouse model. J Virol. 75, 2185–2193.
Punyiczki, M. and Fésüs, L. (1998). Heat shock and apoptosis. The two defense systems of the organism may have overlapping molecular elements. Ann N Y Acad Sci. 85, 67–74. Review.
Puthalakath, H., Huang, D.C., O’reilly, L.A., King, S.M. and Strasser, A. (1999). The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. Mol Cell. 3, 287–296.
Querido, E.R., Marcellus, C., Lai, A., Charbonneau, R., Teodoro, J.G., Ketner, G. and Branton, P.E. (1997). Regulation of p53 levels by the E1B 55-kilodalton protein and E4orf6 in adenovirus-infected cells. J Virol. 71, 3788–3798.
Rabbani, A., Finn, R.M., Ausió, J. (2005). The anthracycline antibiotics: antitumor drugs that alter chromatin structure. BioEssays. 27, 50–56.
Rathmell, J.C. and Thompson, C.B. (1999). The central effectors of cell death in the immune system. Annu Rev Immunol. 17, 781–828.
Reed, J.C. (1997). Cytochrome c: can’t live with it—can’t live without it. Cell. 91, 559–562.
Rehak, M., Csuka, I., Szepessy, E. and Bánfalvi, G. (2000). Subphases of DNA replication in Drosophila cells. DNA Cell Biol. 19, 607–612.
Rhim, J.A., Connor, W., Dixon, G.H., Harendza, C.J., Evenson, D.P., Palmiter, R.D. and Brinster, R.L. (1995). Expression of an avian protamine in transgenic mice disrupts chromatin structure in spermatozoa. Biol Reprod. 52, 20–32.
Roest, H.P., Van Klaveren, J., De Wit, J., Van Gurp, C.G., Koken, M.H.M., Vermey, M., Van Roijen, J.H., Hoogerbrugge, W., Vreeburg, J.T.M., Baarends, W.M., Bootsma, D., Grootegoed, J.A. and J. H. J. Hoeijmakers, J.H.J. (1996). Inactivation of the HR6B ubiquitin-conjugating DNA repair enzyme in mice causes male sterility associated with chromatin modification cell. 86, 799–810.
Rothe, M., Pan, M.G., Henzel, W.J., Ayres, T.M. and Goeddel, D.V. (1995). The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell. 83, 1243–1252.
Roth, J., Dobbelstein, M., Freedman, D.A., Shenk, T. and Levine, A.J. (1998). Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein. EMBO J. 17, 554–564.
Roth, J., König, C., Wienzek, S., Weigel, S., Ristea, S. and Dobbelstein, M. (1998). Inactivation of p53 but not p73 by adenovirus type 5 E1B 55-kilodalton and E4 34-kilodalton oncoproteins. J Virol. 72, 8510–8516.
Rössler, U., Hornhardt, S., Seidl, C., Müller-Laue, E., Walsh, L., Panzer, W., Schmid, E., Senekowitsch-Schmidtke, R. and Gomolka, M. (2006). The sensitivity of the alkaline comet assay in detecting DNA lesions induced by X rays, gamma rays and alpha particles. Radiat Prot Dosimetry. 122, 154–159.
Rotter, V. (1983). p53, a transformation-related cellular-encoded protein, can be used as a biochemical marker for the detection of primary mouse tumour cells. Proc Natl Acad Sci USA. 80, 2613–2617.
Rotter, V., Wolf, D. and Nicolson, G.L. (1984). The expression of transformation-related protein p53 and p53-containing mRNA in murine RAW117 large cell lymphoma cells of differing metastatic potential. Clin Exp Metastasis. 2, 199–204.
Roy, N., Mahadevan, M.S., Mclean, M., Shutler, G., Yaraghi, Z., Farahani, R., Baird, S.,Besnerjohnston, A., Lefebvre, C., Kang, X.L., Salih, M., Aubry, H., Tamai, K., Guan, X.P., Ioannou, P., Crawford, T.O., Dejong, P.J., Surh, L., Ikeda, J.E., Korneluk, R.G. and Mackenzie, A.(1995). Thegene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell. 80, 167–178.
Ruttan, C.C. and Glickman, B.W. (2002). Coding variants in human double-strand break DNA repair genes. Mutat Res. 509, 175–200.
Salvesen, G.S. and Dixit, V.M. (1997). Caspases: intracellular signaling by proteolysis. Cell. 91, 443–446.
Sarafin, T.A. and Bredesen, D.E. (1994). Is apoptosis mediated by reactive oxygen species? Free Radical Res. 21, 1–8.
Sarnow, P., Ho, Y.S., Williams, J. and Levine, A.J. (1982). Adenovirus E1b-58kd tumour antigen and SV40 large tumour antigen are physically associated with the same 54 kd cellular protein in transformed cells. Cell. 28, 387–394.
Sastre, J., Borrás, C., GARCIA-Sala, D., Lloret, A., Pallardo, F.V. and Vina, J. (2002). Mitochondrial damage in aging and apoptosis. Ann N Y Acad Sci. 959, 448–451.
Sattler, M., Liang, H., Nettesheim, D., Meadows, R.P., Harlan, J.E., Eberstadt, M., Yoon, H.S., Shuker, S.B., Chang, B.S., Minn, A.J., Thompson, C.B., Fesik, S.W. (1997). Structure of Bcl-x(l)-Bak peptide complex recognition between regulators of apoptosis. Science. 275, 983–986.
Sauter, B., Albert, M.L., Francisco, L., Larsson, M., Somersan, S. and Bhardwaj, N. (2000). Consequences of cell death: exposure to necrotic tumour cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J Exp Med. 191, 423–433.
Scaffidi, C., Fulda, S., Srinivasan, A., Friesen, C., Li, F., Tomaselli, K.J., Debatin, K.M., Krammer, P.H. and Peter, M.E. (1998). Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17, 1675–1687.
Scheffner, M., Werness, B.A., Huibregtse, J.M., Levine, A.J. and Howley, P.M. (1990). The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 63, 1129–1136.
Schou, K.B., Schneider, L., Christensen, S.T. and Hoffmann, E.K. (2007). Early-stage apoptosis is associated with DNA-damage-independent ATM phosphorylation and chromatin decondensation in NIH3T3 fibroblasts. Cell Biol Int. 2007 Sep 7; [Epub ahead of print].
Schwartz, L.M., Smith, S.W., Jones, M.E.E. and Osborne, B.A. (1993). Do All programmed cell deaths occur via apoptosis? Proc Natl Acad Sci USA. 90, 980–984.
Schwartzman, R.A. and Cidlowski, J.A. (1993). Mechanism of tissue-specific induction of internucleosomal deoxyribonucleic acid cleavage activity and apoptosis by glucocorticoids. Endocrinology 133, 591–599.
Shaman, J.A., Prisztoka, R., Ward, S.W. (2006). Topoisomerase IIB and an extracellular nuclease interact to digest sperm DNA in an apoptotic-like manner. Biol Reprod. 75, 741-748.
Shapiro, H.M. (2003). Practical flow cytometry 4th edn. (Hoboken, Wiley-Liss).
Shiokawa, D., Ohyama, H., Yamada, T., Takahashi, K. and Tanuma, S-I. (1994). Identification of an endonuclease responsible for apoptosis in rat thymocytes. Eur J Biochem. 226, 23–30.
Seshagiri, S. and Miller, L.K. (1997). Caenorhabditis elegans CED-4 stimulates CED-3 processing and CED-3-induced apoptosis. Curr Biol. 7, 455–460.
Sherman, M.A., Powell, D.R. and Brown, M.A. (2002). IL-4 induces the proteolytic processing of mast cell STAT6. J Immunol. 169, 3811–3818.
Sigal, A. and Rotter, V. (2000). Oncogenic mutations of the p53 tumour suppressor: the demons of the guardian of the genome. Cancer Res. 60, 6788–6793.
Smith, C.A., Farrah, T. and Goodwin, R.G. (1994). The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell. 76, 959–962.
Spector, M.S., Desnoyers, S., Hoeppner, D.J. and Hengartner, M.O. (1997). Interaction between the C. elegans cell-death regulators CED-9 and CED-4. Nature 385, 6553–656.
Sperandio, S., D.E. Belle, I. and Bredesen, D.E. (2000). An alternative, nonapoptotic form of programmed cell death. Proc Natl Acad Sci USA. 97, 14376–14381.
Šrám, R.J., Podrazilová, K., Dejmek, D., Mračková, G. and Pilčìk, T. (1998). Single cell gel electrophoresis assay: sensitivity of peripheral white blood cells in human population studies. Mutagenesis. 13, 99–103.
Srinivasula, S.M., Hegder, S., Aleh, A., Datta, P., Shiozaki, E., Chai, J.J., Lee, R.A., Robbins, P.D., Fernandes-Alnemri, T., Shi, Y.G. and Alnemri, E.S. (2001). A conserved XIAPinteractionmotif in caspase-9 and Smac/DIABLOregulates caspase activity and apoptosis. Nature 410, 112–116.
Steegenga, W.T., Riteco, N., Jochemsen, A.G., Fallaux, F.J. and Bos, J.L. (1998). The large E1B protein together with the E4orf6 protein target p53 for active degradation in adenovirus infected cells. Oncogene. 16, 349–357.
Strahl, B.D. and Allis, C.D. (2000). The language of covalent histone modifications. Nature. 403, 41–45.
Strasser, A., Whittingham, S., Vaux, D.L., Bath, M.L., Adams, J.M., Cory, S. and Harris, A.W. (1991). Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc Natl Acad Sci USA. 88, 8661–8665.
Suda, T., Takahashi, T., Golstein, P. and Nagata, S. (1993). Molecular cloning and expression of the Fas ligand, a novel member of the tumour necrosis factor family. Cell. 75, 1169–1178.
Sugito, K., Yamane, M., Hattori, H., Hayashi, Y., Tohnai, I., Ueda, M., Tsuchida, N. and Ohtsuka, K. (1995). Interaction between hsp70 and hsp40, eukaryotic homologues of DnaK and DnaJ, in human cells expressing mutant-type p53. FEBS Lett. 358, 161–164.
Sulston, J.E. (1976). Post-embryonic development in the ventral cord of Caenorhabditis elegans. Philosoph Trans Roy Soc Lond. Series B: Biol Sci. 275, 287–297.
Sun, X.M., Snowden, R.T., Dinsdale, D., Ormerod, M.G. and Cohen, G.M. (1993). Changes in nuclear chromatin precede internucleosomal DNA cleavage in the induction of apoptosis by etoposide. Biochem Pharmacol. 2, 187–195.
Susin, S.A., Daugas, E., Ravagnan, L., Samejima, K., Zamzami, N., Loeffler, M., Costantini, P., Ferri, K.F., Irinopoulou, T., Prevost, M.C., Brothers, G., Mak, T.W., Penninger, J., Earnshaw, W.C. and Kroemer, G. (2000). Two distinct pathways leading to nuclear apoptosis. J Exp Med. 192, 571–580.
Susin, S.A., Zamzami, N., Castedo, M., Hirsch, T., Marchetti, P., Macho, A., Daugas, E., Geuskens, M. and Kroemer, G. (1996). Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J Exp Med. 184, 1331–1341.
Suzuki, H., Tomida, A. and Tsuruo, T. (2001). Dephosphorylated hypoxia-inducible factor 1alpha as a mediator of p53-dependent apoptosis during hypoxia. Oncogene. 20, 5779–5788.
Szepessy, E., Nagy, G., Jenei Z., Serfozo, Z., Csuka, I., James, J. and Bánfalvi, G. (2003). Multiple subphases of DNA repair and poly(ADP-ribose) synthesis in Chinese hamster ovary (CHO-K1) cells. Eur J Cell Biol. 82, 201–207.
Szondy, Z., Reichert, U., Bernardon, J.M., Michel, S., Tòth, R., Ancian, P., Ajzner, E. and Fesus, L. (1997). Induction of apoptosis by retinoids and retinoic acid receptor gamma-selective compounds in mouse thymocytes through a novel apoptosis pathway. Mol Pharmacol. 51, 972–982.
Tamm, I., Wang, Y., Sausville, E., Scudiero, D.A., Vigna, N., Oltersdorf, T. and Reed, J.C. (1998). IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res. 58, 5315–5320.
Tang, D. and Kidd, V.J. (1998). Cleavage of DFF-45/ICAD by multiple caspases is essential for its function during apoptosis. Biochem. J. 273, 28549–52.
Tang, J.Y., Hwang, B.J., Ford, J.M., Hanawalt, P.C., Chu, G. (2000). Xeroderma pigmentosum p48 gene enhances global genomic repair and suppresses UV-induced mutagenesis. Mol Cell. 5, 737–744.
Tarachand, U. and D’souza, S.J. (1999). Apoptosis of rat decidual cells: site specific initiation and related biochemical changes. Ind J Exp Biol 37, 758–761.
Tata, J.R. (1966). Requirement for RNA and protein synthesis for induced regression of the tadpole tail in organ culture. Dev Biol 13, 77–94.
Tewari, M. and Dixit, V.M. (1995). Fas- and tumour necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product. J Biol Chem270, 3255–3260.
Thompson, C.B. (1995). Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456–1462.
Thornberry, N.A. and Lazebnik, Y. (1998). CASPASES: enemies within. Science. 281, 1312–1316.
Tominaga, O., Hamelin, R., Trouvat, V., Salmon, R.J., Lesec, G., Thomas, G. and Remvikos, Y. (1993). Frequently elevated content of immunochemically defined wild-type p53 protein in colorectal adenomas. Oncogene. 8, 2653–2658.
Trauth, B.C., Klas, C., Peters, A.M., Matzku, S., Moller, P., Falk, W., Debatin, K.M. and Krammer, P.H. (1989). Monoclonal antibody-mediated tumour regression by induction of apoptosis. Science 245, 301–305.
Tsujimoto, Y. and Croce, C.M. (1986). Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc Natl Acad Sci USA. 83, 5214–5218.
Uddin, S., Kottegoda, S., Stigger, D., Platanias, L.C. and Wickrema, A. (2000). Activation of the Akt/FKHRL1 pathway mediates the antiapoptotic effects of erythropoietin in primary human erythroid progenitors. Biochem Biophys Res Com. 275, 16–19.
Ura, S., Masuyama, N., Graves, J.D. and Gotoh, Y. (2001). MST1-JNK promotes apoptosis via caspase-dependent and independent pathways. Genes Cells. 6, 519–30.
Uren, A.G., Pakusch, M., Hawkins, C.J., Puls, K.L. and Vaux, D.L. (1996). Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumour necrosis factor receptor-associated factors. Proc Natl Acad Sci USA. 93, 4974–4978.
Uren, A., O’rourke, K., Aravind, L., Pisabarro, M., Seshagiri, S., Koonin, E. and DIXIT, V. (2000). Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma. Mol Cell 6, 961–967.
Van Cruchten, S. and Van Den Broeck, W. (2002). Morphological and biochemical aspects of apoptosis, oncosis and necrosis. Anat Histol Embryol. 31, 214–23. Review.
Van Loo, G., Schotte, P., Van Gurp, M., Demol, H., Hoorelbeke, B., Gevaert, K., Rodriguez, I., Ruiz-Carrillo, A., Vandekerckhove, J., Declercq, W., Beyaert, R. and Vandenabeele, P. (2001). Endonuclease G: a mitochondrial protein released in apoptosis and involved in caspase-independent DNA degradation. Cell Death Differ. 8, 1136–1142.
Van Parijs, L. and Abbas, A.K. (1996). Role of Fas-mediated cell death in the regulation of immune responses. Curr Opin Immunol. 8, 355–361.
Vaux, D.L., Cory, S. and Adams, J.M. (1988). Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335, 440–442.
Vaux, D.L., Haecker, G. and Strasser, A. (1994). An evolutionary perspective on apoptosis. Cell. 76, 777–779.
Vaux, D. L. and Korsmeyer, S.J. (1999). Cell death in development. Cell. 96, 245–254.
Vaux, D.L., Weissman, I.L. and KIM, S.K. (1992). Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2. Science. 258, 1955–1957.
Vercammen, D., Beyaert, R., Denecker, G., Goossens, V., Van Loo, G., Declercq, W., Grooten, J., Fiers, W. and Vandenabeele, P. (1998a). Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumour necrosis factor. J Exp Med. 187, 1477–1485.
Vercammen, D., Brouckaert, G., Denecker, G., Van de Craen, M., Declercq, W., Fiers, W. and Vandenabeele, P. (1998b). Dual signaling of the Fas receptor: initiation of both apoptotic and necrotic cell death pathways. J Exp Med. 188, 919–930.
Verheij, M., Bose, R., Lin, X.H., Yao, B., Jarvis, W.D., Grant, S., Birrer, M.J., Szabo, E., Zon, L.I. and Kyriakis, J.M. (1996). Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature. 380, 75–79.
Vogelstein, B., Lane, D. and Levine, A.J. (2000). Surfing the p53 network. Nature. 408, 307–310.
Voges, D., Zwickl, P. and Baumeister, W. (1999). The 26S proteasome: a molecular machine designed for controlled proteolysis. Annu Rev Biochem. 68, 1015–1068.
Vogt, C. (1842). Untersuchungen uber die Entwicklungsgeschichte der Geburtshelerkroete (Alytes obstetricians). (Solothurn, Jent und Gassman), p. 130.
Walker, N.P.C., Talanian, R.V., Brady, K.D., Dang, L.C., Ferenz, C.R., Franklin, S., Ghayur, T., Hackett, M.C., Hamill, L.D., Herzog, L., Hugunin, M., Houy, W., Mankovich, J.A., Mcguiness, L., Orlewicz, E., Paskind, M., Pratt, C.A., Reis, P., Summani, A., Terranova, M., Welch, J.P., Xiong, L., Moéller, A., Tracey, D.E., Kamen, R. and Wong, W.W. (1994). Cystal structure of the cysteine protease interleukin-1-b-converting enzyme: A (p20/p10)2 homodimer. Cell. 78, 343–352.
Walker, P.R., Leblanc, J. and Sikorska, M. (1997). Evidence that DNA fragmentation in apoptosis is initiated and propagated by single-strand breaks. Cell Death Differ. 4, 506–515.
Wang, G.G., Allis, C.D. and Chi, P. (2007). Chromatin remodeling and cancer, part I: covalent histone modifications. Trends Mol Med. 13, 363–372.
Wang, C., Ivanov, A., Chen, L., Fredericks, W.J., Seto, E. and Rauscher, F.J. III, Chen J. (2005). MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation. EMBO J. 24, 3279–3290.
Widlak, P., Garrard, W.T. (2006). Discovery, regulation, and action of the major apoptotic nucleases DFF40/CAD and endonuclease G. J Cell Biochem. 94, 1078–1087.
Wilson, K.P., Black, J., Thomson, J.A., Kim, E.E., Griffith, J.P., Navia, M.A., Murcko, M.A., Chambers, S.P., Aldape, R.A., Raybuck, S.A. and Livingston, D.J. (1994). Structure and mechanism of interleukin-1-beta converting enzyme. Nature. 370, 270–275.
White, K., Grether, M.E., Abrams, J.M., Young, L., Farrell, K. and Steller, H. (1994). Genetic control of programmed cell death in Drosophila. Science 264, 677–683.
Whitten, J.M. (1969). Cell death during early morphogenesis: parallels between insect limb and vertebrate limb development. Science 163, 1456–1457.
Wiley, S.R., Schooley, K., Smolak, P.J., Din, W.S., Huang, C.-P., Nicholl, J.K., Sutherland, G.R., Davis Smith, T., Rauch, C., Smith, C. A. and Goodwin, R.G. (1995). Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity. 3, 673–682.
Williams, J.R., Little, J.B. and Shipley, W.U. (1974). Association of mammalian cell death with a specific endonucleolytic degradation of DNA. Nature. 252, 754–755.
Woo, E.J., Kim, Y.G., Kim, M.S., Han, W.D., Shin, S., Robinson, H., Park, S.Y. and Oh, B.H. (2004). Structural mechanism for inactivation and activation of CAD/DFF40 in the apoptotic pathway. Mol Cell. 14, 531–539.
Woods, D.B. and Vousden, K.H. (2001). Regulation of p53 function. Exp Cell Res. 264, 56–66.
Wright, W.E., Pereira-Smith, O.M. and Shay, J.W. (1989). Reversible cellular senescence: implications for immortalization of normal human diploid fibroblasts. Mol Cell Biol. 9, 3088–3092.
Wu, Y.-C., Stanfield, G.M., Horvitz, H.R. (2000). NUC-1, a Caenorhabditis elegans DNase II homolog, functions in an intermediate step of DNA degradation during apoptosis. Genes Dev. 14, 536–548.
Wu, D.Y., Wallen, H.D. and Nunez, G. (1997). Interaction and regulation of subcellular localization of CED-4 by CED-9. Science. 275, 1126–1129.
Wyllie, A.H. (1980). Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature. 284, 555–556.
Wyllie, A.H. (1981). Cell death: a new classification separating apoptosis from necrosis. In: Bowen, I. and Lochshin, R.A. (eds). Cell Death in Biology and Pathology. Chapman and Hall, London. pp 9–23.
Wyllie, A.H. and Golstein, P. (2001). More than one way to go. Proc Natl Acad Sci USA. 98, 11–13.
Wyllie, A.H., Kerr, J.F.R. and Currie, A.C. (1980). Cell death: the significance of apoptosis. Int Rev Cytol. 68, 251–305.
Wynford-Thomas, D. (1996). Telomeres, p53 and cellular senescence. Oncology Res. 8, 387–398.
Xue, D. and Horvitz, H.R. (1995). Inhibition of the Caenorhabditis elegans celldeath protease CED-3 by a CED-3 cleavage site in baculovirus p35 protein. Nature. 377, 248–251.
Yang, J., Liu, X., Bhalla, K., Kim, C.N., Ibrado, A.M., Cai, J., Peng, T.I., Jones, D.P. and Wang, X. (1997). Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. 275, 1129–1132.
Yee, K.S. and Vousden, K.H. (2005). Complicating the complexity of p53. Carcinogenesis 26, 1317–1322.
Ye, H., Cande, C., Stephanou, N.C., Jiang, S., Gurbuxani, S., Larochette, N., Daugas, E., Garrido, C., Kroemer, G. and Wu, H. (2002). DNA binding is required for the apoptogenic action of apoptosis inducing factor. Nat Struct Biol. 9, 680–684.
Yin, X.M., Wang, K., Gross, A., Zhao, Y., Zinkel, S., Klocke, B., Roth, K.A. and Korsmeyer, S.J. (1999). Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Nature. 400, 886–891.
Yonehara, S., Ishii, A. and Yonehara, M. (1989). A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumour necrosis factor. J Exp Med. 169, 1747–1756.
Yonish, R.E., Resnitzky, D., Lotem, J., Sachs, L., Kimchi, A. and Oren, M. (1991). Wildtype p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature. 353, 345–347.
Yonish-Rouach, E., Resnitzky, D., Lotem, J., Sachs, L., Kimchi, A. and Oren, M. (1993). p53-mediated cell death: relationship to cell cycle control. Mol Cell Biol. 13, 1415–1423.
Yu, J., Zhang, L., Hwang, P.M., Rago, C., Kinzler, K.W. and Vogelstein, B. (1999). Identification and classification of p53 regulated genes. Proc Natl Acad Sci USA. 96, 14517–14522.
Yuan, J. and Horvitz, H.R. (1992). The Caenorhabditis elegans cell death gene ced-4 encodes a novel protein and is expressed during the period of extensive programmed cell death. Development. 116, 309–320.
Yuan, J., Shaham, S., Ledoux, S., Ellis, H.M. and Horvitz, H.R. (1993). The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1b-converting enzyme. Cell. 75, 641–6452.
Yuyama, K., Yamamoto, H., Nishizaki, I., Kato, T., Sora, I. and Yamamoto, T. (2003). Caspase-independent cell death by low concentrations of nitric oxide in PC12 cells: involvement of cytochrome c oxidase inhibition and the production of reactive oxygen species in mitochondria. J Neurosci Res. 73, 351–363.
Yung, H.W., Bal-Price, A.K., Brown, G.C. and Tolkovsky, A.M. (2004). Nitric oxide-induced cell death of cerebrocortical murine astrocytes is mediated through p53- and Bax-dependent pathways. J Neurochem. 89, 812–821.
Zamora-Avila, D.E., Franco-Molina, M.A., Trejo-Avila, L.M., Rodrìguez-Padilla, C., Reséndez-Pérez, D. and Zapata-Benavides, P. (2007). RNAi silencing of the WT1 gene inhibits cell proliferation and induces apoptosis in the B16F10 murine melanoma cell line. Melanoma Res. 17, 341–8.
Zamzami, N., Marchetti, P., Castedo, M., Zanin, C., Vayssiere, J.-L., Petit, P.X. and Kroemer, G. (1995). Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J Exp Med. 374, 1661–1672.
Zhang, D., Pasternack, M.S., Beresford, P.J., Wagner, L., Greenberg, A.H. and Lieberman, J. (2001). Induction of rapid histone degradation by the cytotoxic T lymphocyte protease Granzyme A. J Biol Chem. 276, 3683–3690.
Zhang, J. and Xu, M. (2002). Apoptotic DNA fragmentation and tissue homeostasis. Trends Cell Biol. 12, 84–89.
Zhivotovsky, B., Cederall, B., Jiang, S., Nicotera, P. and Orrenius, S. (1994). Involvement of Ca$2+$ in the formation of high molecular weight DNA fragments in thymocyte apoptosis; Biophys Biochem Res Commun. 202, 120–127.
Zhivotovsky, B., Orrenius, S., Brustugun, O.T. and Doskeland, S.O. (1998). Injected cytochrome c induces apoptosis. Nature. 391, 449–450.
Zhou, J., Ahn, J., Wilson, S.H. and Prives, C. (2001). A role for p53 in base excision repair. EMBO J. 20, 914–923.
Zou, H., Henzel, W.J., Liu, X.S., Lutsch, G.A. and Wang, X.D. (1997). Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c dependent activation of caspase-3. Cell. 90, 405–413.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Bánfalvi, G. (2009). Apoptosis. In: Apoptotic Chromatin Changes. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-9561-0_4
Download citation
DOI: https://doi.org/10.1007/978-1-4020-9561-0_4
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-9560-3
Online ISBN: 978-1-4020-9561-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)